137 related articles for article (PubMed ID: 7889952)
1. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Gavan TL
J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
[TBL] [Abstract][Full Text] [Related]
3. Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.
Barry AL; Thornsberry C; Gavan TL; Jones RN
J Clin Microbiol; 1984 Nov; 20(5):988-9. PubMed ID: 6439736
[TBL] [Abstract][Full Text] [Related]
4. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
5. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
Barry AL; Jones RN; Gavan TL; Thornsberry C
J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
[TBL] [Abstract][Full Text] [Related]
6. Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.
Barry AL; Fuchs PC; Allen SD; Tenover FC; Jorgensen JH; Reller LB
J Clin Microbiol; 1995 Jan; 33(1):235-8. PubMed ID: 7699050
[TBL] [Abstract][Full Text] [Related]
7. In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits.
Barry AL; Fuchs PC; Allen SD; Brown SD; Jorgensen JH; Tenover FC
J Antimicrob Chemother; 1996 Feb; 37(2):365-9. PubMed ID: 8707749
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
9. Quality control limits for microdilution susceptibility tests with norfloxacin.
Barry AL; Gavan TL; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
J Clin Microbiol; 1987 Jan; 25(1):165-6. PubMed ID: 3098779
[TBL] [Abstract][Full Text] [Related]
10. Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.
Barry AL; Fuchs PC; Allen SD; Jorgensen JH; Tenover FC; Murray PR; Hardy DJ; Baker CN
J Clin Microbiol; 1993 Sep; 31(9):2375-80. PubMed ID: 8408559
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
12. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
Barry AL; Pfaller MA; Fuchs PC; Tenover FC; Reller LB; Allen SD; Hardy DJ; Gerlach EH
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
[TBL] [Abstract][Full Text] [Related]
13. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
Kronvall G
J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
[TBL] [Abstract][Full Text] [Related]
14. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
Houston AK; Jones RN
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):57-9. PubMed ID: 8026158
[TBL] [Abstract][Full Text] [Related]
15. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
[TBL] [Abstract][Full Text] [Related]
17. Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.
Pitkin DH; Sheikh W; Nadler H
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():251-8. PubMed ID: 2808211
[TBL] [Abstract][Full Text] [Related]
18. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II).
Cetinkaya B; Cetinkaya E; Küçükbay H; Durmaz R
Arzneimittelforschung; 1996 Aug; 46(8):821-3. PubMed ID: 9125286
[TBL] [Abstract][Full Text] [Related]
20. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
